Livforsakringsbolaget Skandia’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-110,900
| Closed | -$2.2M | – | 576 |
|
|
2024
Q3 | $2.2M | Buy |
110,900
+36,000
| +48% | +$715K | 0.12% | 131 |
|
|
2024
Q2 | $1.16M | Hold |
74,900
| – | – | 0.09% | 157 |
|
|
2024
Q1 | $1.19M | Hold |
74,900
| – | – | 0.1% | 158 |
|
|
2023
Q4 | $1.26M | Hold |
74,900
| – | – | 0.12% | 157 |
|
|
2023
Q3 | $873K | Sell |
74,900
-3,500
| -4% | -$40.8K | 0.1% | 176 |
|
|
2023
Q2 | $1.05M | Sell |
78,400
-3,900
| -5% | -$52.4K | 0.11% | 160 |
|
|
2023
Q1 | $1.36M | Buy |
82,300
+26,600
| +48% | +$441K | 0.14% | 146 |
|
|
2022
Q4 | $1.04M | Hold |
55,700
| – | – | 0.12% | 161 |
|
|
2022
Q3 | $713K | Hold |
55,700
| – | – | 0.09% | 168 |
|
|
2022
Q2 | $390K | Hold |
55,700
| – | – | 0.03% | 264 |
|
|
2022
Q1 | $462K | Hold |
55,700
| – | – | 0.03% | 281 |
|
|
2021
Q4 | $377K | Buy |
+55,700
| New | +$377K | 0.02% | 323 |
|